UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Intrinsic fibrillation of fast-acting insulin analogs

Journal of diabetes science and technology, 2012-03, Vol.6 (2), p.265-276

2012

Volltextzugriff (PDF)

Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions

Journal of diabetes science and technology, 2015-08, Vol.9 (6), p.1282-1291

2015

Volltextzugriff (PDF)

Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection

Diabetes technology & therapeutics, 2011-04, Vol.13 (4), p.435

2011

Volltextzugriff (PDF)

Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion

Journal of diabetes science and technology, 2012-07, Vol.6 (4), p.743-754

2012

Volltextzugriff (PDF)

Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear

Drug delivery and translational research, 2015-08, Vol.5 (4), p.332-345

2015

Volltextzugriff (PDF)

Continuous glucose monitoring using a novel glucose/galactose binding protein: results of a 12-hour feasibility study with the becton dickinson glucose/galactose binding protein sensor

Diabetes technology & therapeutics, 2011-03, Vol.13 (3), p.309

2011

Volltextzugriff (PDF)

Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences

Biochemical journal, 2002-07, Vol.365 (Pt 2), p.429-440

2002

Volltextzugriff (PDF)

Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta -opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy

The Journal of biological chemistry, 2001-04, Vol.276 (17), p.14092-14099

2001

Volltextzugriff (PDF)

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

Annals of neurology, 2009-08, Vol.66 (2), p.235-244

2009

Volltextzugriff (PDF)

A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland

Familial cancer, 2023-04, Vol.22 (2), p.135-149

2023

Volltextzugriff (PDF)

SB 234551 selective ETA receptor antagonism : Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection

Experimental neurology, 2008-07, Vol.212 (1), p.53-62

2008

Volltextzugriff (PDF)

SB 234551 selective ET A receptor antagonism: Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection

Experimental neurology, 2008-07, Vol.212 (1), p.53-62

2008

Volltextzugriff (PDF)

How long is urinary cytology abnormal after flexible cystoscopy?

BJU international, 2004-09, Vol.94 (4), p.548-551

2004

Volltextzugriff (PDF)

SB 234551 selective ET sub(A) receptor antagonism: Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection

Experimental neurology, 2008-07, Vol.212 (1), p.53-62

2008

Volltextzugriff (PDF)

Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer

The Journal of biological chemistry, 2001-04, Vol.276 (17), p.14092-14099

2001

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(11)
Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Male
(7)
Female
(6)
Adult
(5)
Middle Aged
(5)
Time Factors
(5)
Adolescent
(4)
Hypoglycemic Agents - Administration & Dosage
(4)
Young Adult
(4)
Biological And Medical Sciences
(3)
Diabetes Mellitus, Type 1 - Blood
(3)
Diabetes Mellitus, Type 1 - Drug Therapy
(3)
Insulin
(3)
Insulin - Administration & Dosage
(3)
Medical Sciences
(3)
Needles
(3)
Treatment Outcome
(3)
Biochemistry & Molecular Biology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intrinsic fibrillation of fast-acting insulin analogs

Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions

Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection

Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion

Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear

Continuous glucose monitoring using a novel glucose/galactose binding protein: results of a 12-hour feasibility study with the becton dickinson glucose/galactose binding protein sensor

Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences

Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta -opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland

SB 234551 selective ETA receptor antagonism : Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection

SB 234551 selective ET A receptor antagonism: Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection

How long is urinary cytology abnormal after flexible cystoscopy?

SB 234551 selective ET sub(A) receptor antagonism: Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection

Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer

Suchergebnisse filtern